Work

Fibulin-1 Is a Marker for Arterial Extracellular Matrix Alterations in Type 2 Diabetes

Year: 2011

Type: article

Study design: Observational Study

Source: Clinical Chemistry

DOI: 10.1373/clinchem.2011.162966

Authors: Claudia Cangemi, Vibe Skov, Michael Kjaer Poulsen, Jonas Funder, Waleed O Twal, Mari-Anne Gall, Vibeke Hjortdal, Marie Louise Jespersen, Torben A Kruse, Jan Aagard, Hans-Henrik Parving, Steen Knudsen, Poul-Flemming Høilund-Carlsen, Peter Rossing, Jan Erik Henriksen, William Scott Argraves, Lars Melholt Rasmussen

Institutions: University of Southern Denmark, Odense University Hospital, Institute of Molecular Medicine, Aarhus University, Aarhus University Hospital, Medical University of South Carolina, Steno Diabetes Center Copenhagen, University of Copenhagen, Medical Prognosis Institute (Denmark)

Language: English

Topic: Cardiovascular Health and Disease Prevention

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Hjerteforeningen, Sundhed og Sygdom, Det Frie Forskningsråd, Novo Nordisk Fonden, National Institutes of Health, National Heart, Lung, and Blood Institute

Award: Fibulin-1 Regulation of the DiGeorge Syndrome Pathogenesis Pathway

OpenAlex ID: W2144200716

FWCI: 5.483

Cites: 40

Cited by: 80

Related to: 10